Table 1.
Inhibition rate (IR%) of 1–12 on human cancer K562, HL-60 and HeLa cells at 100 μg/mL. a
| Cells | IR% at 100 μg/mL | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 5-FU | DOC | |
| K562 | 78.5 | 70.5 | 77.0 | 72.9 | 70.9 | 71.5 | 81.6 | 65.5 | 88.1 | 73.3 | 74.9 | 64.2 | 74.1 | 71.8 |
| HeLa | 86.6 | 83.7 | 77.7 | 85.3 | 75.5 | 84.7 | 88.8 | 88.8 | 76.9 | 78.5 | 85.6 | 77.7 | 90.6 | 82.8 |
| HL-60 | 89.4 | 92.1 | 92.9 | 91.8 | 88.0 | 89.0 | 89.0 | 88.9 | 89.3 | 90.6 | 92.0 | 88.5 | 86.3 | 57.1 |
Notes: a The cells were treated with the test samples at the 100 μg/mL for 48 h, and then the inhibition rate (IR%) was determined by the MTT method. 5-FU: 5-flurouracil, DOC: docetaxol.